These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10903263)

  • 21. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis.
    Horianopoulou M; Lambropoulos S; Papafragas E; Falagas ME
    J Chemother; 2005 Oct; 17(5):536-8. PubMed ID: 16323443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.
    Lu Q; Girardi C; Zhang M; Bouhemad B; Louchahi K; Petitjean O; Wallet F; Becquemin MH; Le Naour G; Marquette CH; Rouby JJ
    Intensive Care Med; 2010 Jul; 36(7):1147-55. PubMed ID: 20397007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monotherapy with inhaled colistin for the treatment of patients with ventilator-associated tracheobronchitis due to polymyxin-only-susceptible Gram-negative bacteria.
    Athanassa ZE; Myrianthefs PM; Boutzouka EG; Tsakris A; Baltopoulos GJ
    J Hosp Infect; 2011 Aug; 78(4):335-6. PubMed ID: 21641678
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
    Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
    Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
    Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
    Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia.
    Hraiech S; Brégeon F; Brunel JM; Rolain JM; Lepidi H; Andrieu V; Raoult D; Papazian L; Roch A
    J Antimicrob Chemother; 2012 Oct; 67(10):2452-8. PubMed ID: 22744759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aerosolized colistin in the treatment of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa pneunomia].
    Peral Sánchez D; Armero Ibáñez R; Seller Losada JM; Solaz Roldán C
    Med Clin (Barc); 2007 Sep; 129(10):397. PubMed ID: 17915139
    [No Abstract]   [Full Text] [Related]  

  • 33. New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.
    Sánchez A; Gattarello S; Rello J
    Semin Respir Crit Care Med; 2011 Apr; 32(2):151-8. PubMed ID: 21506051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled colistimethate sodium in ventilator-associated tracheobronchitis due to multidrug-resistant Gram-negative bacteria.
    Maskin LP; Setten M; Rodríguez PO; Bonelli I; Attie S; Stryjewski ME; Valentini R
    Int J Antimicrob Agents; 2015 Feb; 45(2):199-200. PubMed ID: 25459739
    [No Abstract]   [Full Text] [Related]  

  • 35. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
    Obritsch MD; Fish DN; MacLaren R; Jung R
    Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
    Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
    J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii.
    Rigatto MH; Ribeiro VB; Konzen D; Zavascki AP
    Infection; 2013 Apr; 41(2):321-8. PubMed ID: 23124906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.
    Paksu MS; Paksu S; Karadag A; Sensoy G; Asilioglu N; Yildizdas D; Akyildiz BN; Kendirli T; Demirkol D; Akgun M; Alp E; Ciftci E; Guney AK; Murat N
    Int J Antimicrob Agents; 2012 Aug; 40(2):140-4. PubMed ID: 22727770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colistin: an update on the antibiotic of the 21st century.
    Biswas S; Brunel JM; Dubus JC; Reynaud-Gaubert M; Rolain JM
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.